Neftaly: Hepatitis B and C Diagnosis
Overview
Hepatitis B (HBV) and Hepatitis C (HCV) are viral infections that primarily affect the liver. Early diagnosis is crucial to prevent chronic liver disease, cirrhosis, hepatocellular carcinoma, and to reduce transmission risk. Healthcare professionals must be equipped with knowledge of risk factors, screening strategies, and interpretation of diagnostic tests.
1. Risk Factors
Hepatitis B:
- Unprotected sexual contact with an infected individual
- Perinatal transmission from mother to child
- Exposure to contaminated needles or medical instruments
- Household contact with infected persons
Hepatitis C:
- History of intravenous drug use
- Blood transfusions or organ transplants before 1992
- Hemodialysis patients
- Healthcare workers with occupational exposure
- Unsterilized tattooing or body piercing
2. Clinical Presentation
Both HBV and HCV may be asymptomatic initially. When present, symptoms include:
- Fatigue and malaise
- Jaundice (yellowing of skin and eyes)
- Dark urine and pale stools
- Abdominal discomfort (right upper quadrant)
- Nausea, vomiting, and loss of appetite
Chronic infections often remain silent until significant liver damage occurs.
3. Diagnostic Approach
A. Laboratory Testing
Hepatitis B:
- Serologic Markers:
- HBsAg (Hepatitis B surface antigen): Indicates active infection
- Anti-HBs (Hepatitis B surface antibody): Indicates immunity
- Anti-HBc (Hepatitis B core antibody): Indicates past or ongoing infection
- HBeAg and Anti-HBe: Assess viral replication and infectivity
- Liver Function Tests (LFTs):
- Elevated ALT and AST suggest liver inflammation
- HBV DNA (PCR):
- Quantifies viral load, important for treatment decisions
Hepatitis C:
- HCV Antibody (Anti-HCV):
- Initial screening test; indicates exposure
- HCV RNA (PCR):
- Confirms active infection
- Quantifies viral load
- Genotyping:
- Determines HCV genotype to guide antiviral therapy
B. Imaging and Liver Assessment
- Ultrasound: To assess liver size, fibrosis, or cirrhosis
- FibroScan / Elastography: Non-invasive assessment of liver fibrosis
- Liver biopsy: Rarely used, reserved for complex cases
4. Screening Recommendations
- High-risk groups should be screened regularly (e.g., healthcare workers, people living with HIV, individuals with multiple sexual partners, intravenous drug users).
- Pregnant women: Screen for HBV to prevent perinatal transmission.
- Blood donors: Mandatory screening for HBV and HCV.
5. Counseling and Follow-Up
- Discuss transmission prevention strategies (safe sex, safe injections, vaccination for HBV).
- Explain the importance of adherence to follow-up appointments for monitoring liver function and viral load.
- Provide emotional support, especially for newly diagnosed patients.
6. Key Points for Healthcare Professionals
- Early detection is critical for preventing chronic liver disease.
- Understand the difference between HBV and HCV serology for accurate interpretation.
- Tailor screening and monitoring based on patient risk factors and comorbidities.
- Link patients promptly to antiviral therapy when indicated.
This content can also be formatted into training modules with diagrams showing the HBV and HCV lifecycle, flowcharts for diagnostic pathways, and checklists for risk assessment.